Kamada Ltd
NASDAQ:KMDA
Intrinsic Value
Kamada Ltd. engages in the development and production of pharmaceutical products. [ Read More ]
The intrinsic value of one KMDA stock under the Base Case scenario is 5.87 USD. Compared to the current market price of 5.06 USD, Kamada Ltd is Undervalued by 14%.
Valuation Backtest
Kamada Ltd
Run backtest to discover the historical profit from buying and selling KMDA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Kamada Ltd
Current Assets | 170m |
Cash & Short-Term Investments | 55.6m |
Receivables | 25.8m |
Other Current Assets | 88.5m |
Non-Current Assets | 184.9m |
PP&E | 36m |
Other Non-Current Assets | 149m |
Current Liabilities | 49.6m |
Accounts Payable | 24.8m |
Other Current Liabilities | 24.8m |
Non-Current Liabilities | 61.3m |
Long-Term Debt | 7.4m |
Other Non-Current Liabilities | 53.9m |
Earnings Waterfall
Kamada Ltd
Revenue
|
142.5m
USD
|
Cost of Revenue
|
-87m
USD
|
Gross Profit
|
55.5m
USD
|
Operating Expenses
|
-45.4m
USD
|
Operating Income
|
10.1m
USD
|
Other Expenses
|
-1.8m
USD
|
Net Income
|
8.3m
USD
|
Free Cash Flow Analysis
Kamada Ltd
What is Free Cash Flow?
KMDA Profitability Score
Profitability Due Diligence
Kamada Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Kamada Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
KMDA Solvency Score
Solvency Due Diligence
Kamada Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Score
Kamada Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KMDA Price Targets Summary
Kamada Ltd
According to Wall Street analysts, the average 1-year price target for KMDA is 12.24 USD with a low forecast of 11.11 USD and a high forecast of 13.65 USD.
Shareholder Return
KMDA Price
Kamada Ltd
Average Annual Return | -7.59% |
Standard Deviation of Annual Returns | 21.29% |
Max Drawdown | -68% |
Market Capitalization | 290.8m USD |
Shares Outstanding | 57 479 528 |
Percentage of Shares Shorted | 0.13% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Contact
IPO
Employees
Officers
The intrinsic value of one KMDA stock under the Base Case scenario is 5.87 USD.
Compared to the current market price of 5.06 USD, Kamada Ltd is Undervalued by 14%.